Katalyze AI
Latest round
- Seed
Last raised
- Jul 2026
Total raised
- $11M
Investors
- 4
About Katalyze AI
Founded in 2022 in Mountain View, US, Katalyze AI develops software that integrates various operational systems for the life sciences industry.Katalyze AI provides an innovative agentic infrastructure tailored specifically for the life sciences industry, designed to streamline operational workflows for pharmaceutical companies. The core product offerings center around an AI-driven platform that integrates various operational systems, allowing data from Manufacturing Execution Systems (MES), Laboratory Information Management Systems (LIMS), Enterprise Resource Planning (ERP), and other sources to form a unified data layer. This integration enables the platform to execute tasks such as batch release management, deviation investigations, and quality control processes with greater efficiency and accuracy. The end users of Katalyze's solutions include large pharmaceutical companies, executives, scientists, and engineers who aim to enhance productivity and reduce operational delays.Katalyze operates on a B2B model, primarily engaging with enterprise clients within the pharmaceutical sector. The company’s revenue structure is based on subscription services for its software platform, where clients pay for access to its agentic infrastructure and AI capabilities. Typical transactions involve annual or multi-year contracts, providing clients with the tools necessary for operational optimization, including streamlining processes like deviation management and enhancing batch release accuracy. The flagship product offers varying service tiers, allowing organizations to choose the level of integration and support that best suits their operational needs. The company plans to launch new products aimed at enhancing its platform's capabilities, although specific release dates have not been announced. Additionally, Katalyze AI aims to expand its market presence in North America, Europe, and Asia, particularly focusing on regions with significant pharmaceutical activity to capitalize on growing demand.
Who invested in Katalyze AI
4 investors across 1 round
See all investors in Katalyze AI
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jul 6, 2026
Amount
$11M
Investors
Questions about Katalyze AI
Who invested in Katalyze AI?
Katalyze AI has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Katalyze AI raised?
Katalyze AI has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Katalyze AI last raise money?
Katalyze AI's most recent round on record is a Seed, in Jul 2026.
What does Katalyze AI do?
Founded in 2022 in Mountain View, US, Katalyze AI develops software that integrates various operational systems for the life sciences industry.
Where is Katalyze AI headquartered?
Katalyze AI is headquartered in Mountain View, US.
Which VCs invest in companies like Katalyze AI?
Among active investors with capital left to deploy, S2G Ventures, CAVU Consumer Partners, Gaingels and Alumni Ventures Group back materials companies at Katalyze AI's stage. Their profiles are linked below.
VCs backing materials startups at Seed
Raising like Katalyze AI? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.